17th Annual Outsourcing in Clinical Trials East Coast 2026

May 12, 2026
May 13, 2026
ET
Hyatt Regency New Brunswick, New Jersey, USA

Explore practical strategies for optimizing outsourced clinical activities, enhancing operational efficiency and leveraging innovation and data management to support successful, cost-effective trial execution. Join us for a two day event filled with case studies, panel discussion and face to face networking opportunities around clinical operations, technology and innovation, and data management.

Clario is sponsoring with a session and exhibit booth this year, and we’d love to meet up! Stop by booth #3 and find out how we can provide the expertise and tools needed to achieve your research goals efficiently and effectively.

Session information:

Date: May 12, 2026

Time: 2:30 pm – 3:00 pm ET

Stream B: Clinical Technology and Innovation

Title: Operationalizing PROs and digital endpoints in early oncology: Faster decisions, better data, stronger Phase III

  • Embedding Patient-Reported Outcomes (PROs) early to streamline oncology trial operations and control cost: How PROs in Phase I/II can deliver clearer tolerability and patient-experience data, supporting faster decisions and more efficient Phase III planning.
  • Operationalizing digital endpoints (eCOA) for speed, quality, and patient-centricity: Practical strategies for configuring eCOA to accelerate startup, and reduce patient burden.
  • Using digital endpoints to enable risk-based oversight and phase-to-phase continuity: How continuous, real-time eCOA data supports centralized/risk-based monitoring, and robustness of regulatory and scientific outcomes.

Speaker

Kelly Dumais headshot

Kelly Dumais, Ph.D.

Senior Director and Global Head of eCOA Science and Consulting at Clario

Dr. Dumais is a scientist with over 15 years of experience in behavioral and life science research. She is currently the Senior Director and Global Head of eCOA Science and Consulting at Clario. She has expertise in the implementation of electronic clinical outcome assessments (eCOA) and the development and validation of patient reported outcomes (PROs) to support labeling claims. She is a subject matter expert in the development of custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability. Furthermore, she has expertise in PRO strategy for oncology clinical trials and has published and presented strategies and outcomes of oncology trials at over 14 conferences and webinars.

Meet with us

Complete this form and we will reach out soon to schedule a time to connect at the event.

If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.